Predictions
Abbott Laboratories
Start price
Target price
Perf. (%)
€86.80
20.04.20
20.04.20
€120.00
04.11.21
04.11.21
28.11%
04.11.21
04.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.80
19.04.20
19.04.20
€80.00
04.11.21
04.11.21
-26.85%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€74.99
04.04.20
04.04.20
-
18.04.20
18.04.20
5.08%
18.04.20
18.04.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€81.44
31.03.20
31.03.20
€95.00
08.04.20
08.04.20
10.79%
08.04.20
08.04.20
Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€69.00
29.03.20
29.03.20
€80.00
04.11.21
04.11.21
-15.28%
17.06.21
17.06.21
Could be worthwhile Investment >10% per year
Undervalued
High dividend yield expected
positive Cash Flow expected
Abbott Laboratories
Start price
Target price
Perf. (%)
€62.80
23.03.20
23.03.20
€70.00
23.03.20
23.03.20
-5.86%
23.03.20
23.03.20
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.00
21.03.20
21.03.20
-
04.04.20
04.04.20
3.16%
04.04.20
04.04.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€76.81
19.03.20
19.03.20
€85.00
19.03.20
19.03.20
-3.91%
19.03.20
19.03.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€126.32
18.03.20
18.03.20
€150.00
12.10.20
12.10.20
6.54%
12.10.20
12.10.20
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Viatris Inc.
Start price
Target price
Perf. (%)
€14.80
17.03.20
17.03.20
€16.00
04.11.21
04.11.21
0.00%
06.01.21
06.01.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Small cyclical dependencies
Top 10 in its market
Pfizer Inc.
Start price
Target price
Perf. (%)
€27.04
17.03.20
17.03.20
€33.21
04.11.21
04.11.21
47.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€70.50
12.03.20
12.03.20
€145.00
04.11.21
04.11.21
119.55%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€117.78
11.03.20
11.03.20
€150.00
04.11.21
04.11.21
20.58%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Perrigo Co. plc
Start price
Target price
Perf. (%)
€45.40
28.02.20
28.02.20
€50.00
04.11.21
04.11.21
-11.45%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Small cyclical dependencies
Known brand
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€127.44
17.01.20
17.01.20
€160.00
04.11.21
04.11.21
83.69%
05.11.21
05.11.21
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.00
22.12.19
22.12.19
€79.00
04.11.21
04.11.21
-3.61%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.38
20.12.19
20.12.19
€86.00
23.04.20
23.04.20
21.40%
23.04.20
23.04.20
Abiomed Inc.
Start price
Target price
Perf. (%)
€177.80
01.12.19
01.12.19
€300.00
04.11.21
04.11.21
49.94%
29.04.21
29.04.21
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€73.20
01.11.19
01.11.19
€98.00
04.11.21
04.11.21
37.84%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€178.02
29.10.19
29.10.19
€190.00
04.11.21
04.11.21
-11.04%
17.06.21
17.06.21
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€257.80
25.10.19
25.10.19
€300.00
04.11.21
04.11.21
-6.13%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€98.78
13.10.19
13.10.19
€120.00
26.10.19
26.10.19
0.30%
26.10.19
26.10.19
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative